Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1700 Owens Street, Suite 205, San Francisco, California
State of incorporation
Delaware
Fiscal year end
November 30
Former names
Nurix, Inc. (to 9/18/2015)
Latest financial report
Q1 2024 - Apr 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 358 % -22.1%
Debt-to-equity 53.8 % +40.8%
Return On Equity -67.1 % -11.5%
Return On Assets -43.6 % -0.21%
Operating Margin -195 % +55.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.2M shares +3.6%
Common Stock, Shares, Outstanding 49.1M shares +3.57%
Entity Public Float 471M USD +6.16%
Common Stock, Value, Issued 49K USD +4.26%
Weighted Average Number of Shares Outstanding, Basic 54.9M shares +1.62%
Weighted Average Number of Shares Outstanding, Diluted 54.9M shares +1.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80.9M USD +94%
Research and Development Expense 193M USD +3.29%
General and Administrative Expense 44.9M USD +16.3%
Operating Income (Loss) -157M USD +14.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -41.4M USD -1.71%
Income Tax Expense (Benefit) 90K USD
Net Income (Loss) Attributable to Parent -145M USD +18.9%
Earnings Per Share, Basic -2.66 USD/shares +24.2%
Earnings Per Share, Diluted -2.66 USD/shares +24.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49.8M USD +48.4%
Marketable Securities, Current 217M USD -27.1%
Cash, Cash Equivalents, and Short-term Investments 244M USD -11.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2M USD
Assets, Current 251M USD -13%
Property, Plant and Equipment, Net 17.9M USD +0.87%
Operating Lease, Right-of-Use Asset 29.3M USD +168%
Other Assets, Noncurrent 3.34M USD -13%
Assets 313M USD -15.5%
Accounts Payable, Current 5.92M USD +5.13%
Employee-related Liabilities, Current 16.8M USD +150%
Contract with Customer, Liability, Current 46.1M USD +20.3%
Liabilities, Current 87.6M USD +35.1%
Contract with Customer, Liability, Noncurrent 34.5M USD +31.9%
Operating Lease, Liability, Noncurrent 21.8M USD +328%
Liabilities 144M USD +49.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -350K USD +89.2%
Retained Earnings (Accumulated Deficit) -587M USD -32.7%
Stockholders' Equity Attributable to Parent 169M USD -38.4%
Liabilities and Equity 313M USD -15.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42M USD +13.4%
Net Cash Provided by (Used in) Financing Activities 1.62M USD +9.66%
Net Cash Provided by (Used in) Investing Activities 35.5M USD +121%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.1M shares +3.57%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.81M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.6M USD -67.7%
Deferred Tax Assets, Valuation Allowance 194M USD +40%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 203M USD +43.1%
Operating Lease, Liability 30.6M USD +156%
Payments to Acquire Property, Plant, and Equipment 2.88M USD +26.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -142M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid 42.4M USD -9.13%
Property, Plant and Equipment, Gross 46.2M USD +18.2%
Operating Lease, Liability, Current 7.31M USD +31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.57M USD -38.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.65M USD +9.54%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +101%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.8M USD +2652%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.91M USD -32.7%
Deferred Tax Assets, Operating Loss Carryforwards 92.1M USD +9.97%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 15.5M USD +51.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.99M USD +12.1%
Operating Lease, Payments 1.92M USD +38.2%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD -100%
Current Federal Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Net of Valuation Allowance 8.94M USD +171%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%